Press releases

- DZNE and Charité work together: with joined forces against neurodegenerative diseases

The DZNE and Charité - Universitätsmedizin Berlin are internationally leading institutions for research in the field of neurodegenerative diseases. Now, both have signed a cooperation agreement to seal their close scientific collaboration. The objective is to combine…

Read more

- Experience Leads to the Growth of New Brain Cells

How do organisms evolve into individuals that are distinguished from others by their own personal brain structure and behavior? Scientists in Dresden, Berlin, Münster, and Saarbrücken have now taken a decisive step towards clarifying this question. Using mice as an animal…

Read more

- Ground breaking ceremony: Ministers Schulze and Wanka kick off construction of the new DZNE building 110 million Euro for neuroscience

A traditional ground breaking ceremony signaled the start of construction work on the new facility for the German Center for Neurodegenerative Diseases (DZNE) on the Venusberg in Bonn, on the grounds of the university clinic. With an area of nearly 16,000 square meters and…

Read more

- Transmission routes of spreading protein particles

In diseases like Alzheimer’s and Parkinson’s endogenous proteins accumulate in the brain, eventually leading to the death of nerve cells. These deposits, which consist of abnormally formed proteins, are supposed to migrate between interconnected areas of the brain, thereby…

Read more

- Misplaced molecules: new insights into the causes of dementia

A team of German and Belgian researchers has succeeded in gaining new insights into the causes of certain movement disorders and forms of dementia. Scientists including Bettina Schmid and Christian Haass from the DZNE in Munich and the LMU were able to reproduce disease…

Read more

- Researchers find controlling element of Huntington’s disease

A three molecule complex may be a target for treating Huntington’s disease, a genetic disorder affecting the brain. This finding by an international research team including scientists from the German Center for Neurodegenerative Diseases (DZNE) in Bonn and the University of…

Read more

- Researchers decipher modus operandi of potential Alzheimer’s drug

The chemical compound known as “methylene blue” is a potential candidate for treating Alzheimer’s, as it prevents the harmful clumping of so-called tau proteins typically associated with this disease. However, until now it was unknown why methylene blue had this effect.…

Read more

- Protein “filmed” while unfolding at atomic resolution

Goettingen, February 11th, 2013. When proteins get “out of shape”, the consequences can be fatal. They lose their function and in some cases form insoluble, toxic clumps that damage other cells and can cause severe diseases such as Alzheimer’s or Parkinson’s. Researchers at…

Read more

- Translation error tracked in the brain of dementia patients

Scientists identify enigmatic aggregates linked to neurodegenerative diseases

Read more

- Brain research: memories come quicker than expected

Magdeburg/London, January 18th, 2013. The brain can recall memories faster than previously assumed. A team of experts under the direction of neuroscientist Emrah Düzel, who is based in Magdeburg, Germany, was able to show this through a series of memory tests. 31 test…

Read more

Welcome to our website, here you can inform yourself basically cookie-free.

We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.

Your browser allows the setting of cookies: